About FEMSelect
FEMSelect is a company based in Modi'in-maccabim-re'ut (Israel) founded in 2012. It operates as a HealthTech and Direct-to-Consumer (D2C). FEMSelect has raised $9 million across 1 funding round from investors including New Age Ventures, Triventures and Robin Hood Ventures. FEMSelect offers products and services including EnPlace and Elitone. FEMSelect operates in a competitive market with competitors including Pharmiva, AVeta Medical, Bioceptive, Madorra and Aqueduct Medical, among others.
- Headquarter Modi'in-maccabim-re'ut, Israel
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Femselect Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$9 M (USD)
in 1 rounds
-
Latest Funding Round
$9 M (USD), Series B
Oct 19, 2022
-
Investors
New Age Ventures
& 8 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of FEMSelect
FEMSelect offers a comprehensive portfolio of products and services, including EnPlace and Elitone.
A minimally invasive treatment for pelvic organ prolapse.
A device addressing pelvic floor health for women.
People of FEMSelect
Unlock access to complete
Unlock access to complete
Funding Insights of FEMSelect
FEMSelect has successfully raised a total of $9M through 1 strategic funding round. The most recent funding activity was a Series B round of $9 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in FEMSelect
FEMSelect has secured backing from 9 investors, including venture fund investors. Prominent investors backing the company include New Age Ventures, Triventures and Robin Hood Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital-backed startup studio focused on deep tech, healthcare, AI, and multiple sectors
|
Locked | Locked | Locked | |
|
Venture capital firm investing in early stage healthcare startups
|
Locked | Locked | Locked | |
|
Early-stage investments are made in high-growth startups by this group.
|
Locked | Locked | Locked |
Investor details for FEMSelect
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by FEMSelect
Investment portfolio details for FEMSelect
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - FEMSelect
Detailed financials for FEMSelect
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Femselect Comparisons
Peer comparison for FEMSelect
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of FEMSelect
FEMSelect operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmiva, AVeta Medical, Bioceptive, Madorra and Aqueduct Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of smart medical devices against bacterial vaginosis in women
|
|
| Locked | Locked | Locked |
Non-hormonal device for menopause symptoms is developed using wound-healing process.
|
|
| Locked | Locked | Locked |
Medical devices for gynecological procedures are developed.
|
|
| Locked | Locked | Locked |
Therapeutic device for vaginal atrophy and dryness treatment is provided.
|
|
| Locked | Locked | Locked |
Develops cervical dilator devices for intrauterine procedures.
|
Detailed competitors of FEMSelect
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Femselect
Complete news archive for FEMSelect
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about FEMSelect
FEMSelect was founded in 2012 and raised its 1st funding round 10 years after it was founded.
FEMSelect is headquartered in Modi'in-maccabim-re'ut, Israel. It is registered at Modi'in-maccabim-re'ut, Central District, Israel.
FEMSelect is a funded company, having raised a total of $9M across 1 funding round to date.
Solutions for womens pelvic health are developed by FEMSelect. The company specializes in minimally invasive treatments for pelvic organ prolapse, affecting millions of women globally. Products like EnPlace, an FDA-cleared same-day procedure, are offered to help women return to normal activities quickly. The focus is on innovative medical devices within the healthcare sector, targeting womens health challenges. Support for medical professionals and patients is provided through educational resources and specialist networks.
FEMSelect's top competitors include Madorra, Bioceptive and AVeta Medical.
FEMSelect offers EnPlace and Elitone.
FEMSelect has 9 investors. Key investors include New Age Ventures, Triventures, Robin Hood Ventures, Mid Atlantic Bio Angels, and MEDA Angels.